World Journal of Cardiology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1405)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

HTML

849

Figures (1-4)

105

Tables (1-1)

102

Sum=1086

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

163

Sum=228

Publishing Process of This Article

Item

Count

Browse

Download

Sum=11

Aug 26, 2024 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Grubić Rotkvić P, Rotkvić L, Đuzel Čokljat A, Cigrovski Berković M. Sodium-dependent glucose transporter 2 inhibitors effects on myocardial function in patients with type 2 diabetes and asymptomatic heart failure. World J Cardiol 2024; 16(8): 448-457 [PMID: 39221192 DOI: 10.4330/wjc.v16.i8.448]
URL:	https://www.wjgnet.com/1949-8462/full/v16/i8/448.htm

Number	Citing Articles
1	Chun-Han Cheng, Wen-Rui Hao, Tzu-Hurng Cheng. Sodium-dependent glucose transporter 2 inhibitors: Transforming diabetic cardiomyopathy management. World Journal of Cardiology 2024; 16(12): 781-786 doi: 10.4330/wjc.v16.i12.781 Abstract(26) \| Core Tip(19) \| Full Article(HTML)(102) \| Full Article with Cover (PDF)-972K(5) \| Audio-396K(0) \| Peer-Review Report-182K(3) \| Answering Reviewers-156K(3) \| Full Article (PDF)-383K(7) \| Full Article (XML)-58K(2) \| Times Cited (0) \| Total Visits (216) \| Open
2	Yan-Xi Zhang, Hai-Sheng Hu, Bao-Qing Sun. Effectiveness and mechanisms of sodium-dependent glucose transporter 2 inhibitors in type 2 diabetes and heart failure patients. World Journal of Cardiology 2024; 16(10): 611-615 doi: 10.4330/wjc.v16.i10.611 Abstract(88) \| Core Tip(80) \| Full Article(HTML)(377) \| Full Article with Cover (PDF)-683K(18) \| Audio-346K(0) \| Peer-Review Report-328K(14) \| Answering Reviewers-223K(9) \| Full Article (PDF)-373K(31) \| Full Article (XML)-80K(10) \| Times Cited (0) \| Total Visits (938) \| Open
3	Mohamed H Laimoud, Ismail R Raslan. Effects of sodium-dependent glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus and asymptomatic heart failure. World Journal of Cardiology 2024; 16(11): 665-668 doi: 10.4330/wjc.v16.i11.665 Abstract(82) \| Core Tip(71) \| Full Article(HTML)(261) \| Full Article with Cover (PDF)-609K(17) \| Audio-2624K(2) \| Peer-Review Report-247K(8) \| Answering Reviewers-245K(11) \| Full Article (PDF)-348K(22) \| Full Article (XML)-58K(12) \| Times Cited (0) \| Total Visits (645) \| Open
4	Panayotis K Vlachakis, Panagiotis Theofilis, Dimitris Tousoulis. SGLT2 inhibitors in the prevention of diabetic cardiomyopathy: Targeting the silent threat. World Journal of Cardiology 2024; 16(11): 669-672 doi: 10.4330/wjc.v16.i11.669 Abstract(78) \| Core Tip(68) \| Full Article(HTML)(319) \| Full Article with Cover (PDF)-611K(12) \| Audio-665K(0) \| Peer-Review Report-179K(9) \| Answering Reviewers-100K(11) \| Full Article (PDF)-354K(22) \| Full Article (XML)-44K(11) \| Times Cited (0) \| Total Visits (723) \| Open

Number	Citing Articles
1	Chun-Han Cheng, Wen-Rui Hao, Tzu-Hurng Cheng. Sodium-dependent glucose transporter 2 inhibitors: Transforming diabetic cardiomyopathy management. World Journal of Cardiology 2024; 16(12): 781-786 doi: 10.4330/wjc.v16.i12.781 Abstract(26) \| Core Tip(19) \| Full Article(HTML)(102) \| Full Article with Cover (PDF)-972K(5) \| Audio-396K(0) \| Peer-Review Report-182K(3) \| Answering Reviewers-156K(3) \| Full Article (PDF)-383K(7) \| Full Article (XML)-58K(2) \| Times Cited (0) \| Total Visits (216) \| Open
2	Yan-Xi Zhang, Hai-Sheng Hu, Bao-Qing Sun. Effectiveness and mechanisms of sodium-dependent glucose transporter 2 inhibitors in type 2 diabetes and heart failure patients. World Journal of Cardiology 2024; 16(10): 611-615 doi: 10.4330/wjc.v16.i10.611 Abstract(88) \| Core Tip(80) \| Full Article(HTML)(377) \| Full Article with Cover (PDF)-683K(18) \| Audio-346K(0) \| Peer-Review Report-328K(14) \| Answering Reviewers-223K(9) \| Full Article (PDF)-373K(31) \| Full Article (XML)-80K(10) \| Times Cited (0) \| Total Visits (938) \| Open
3	Mohamed H Laimoud, Ismail R Raslan. Effects of sodium-dependent glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus and asymptomatic heart failure. World Journal of Cardiology 2024; 16(11): 665-668 doi: 10.4330/wjc.v16.i11.665 Abstract(82) \| Core Tip(71) \| Full Article(HTML)(261) \| Full Article with Cover (PDF)-609K(17) \| Audio-2624K(2) \| Peer-Review Report-247K(8) \| Answering Reviewers-245K(11) \| Full Article (PDF)-348K(22) \| Full Article (XML)-58K(12) \| Times Cited (0) \| Total Visits (645) \| Open
4	Panayotis K Vlachakis, Panagiotis Theofilis, Dimitris Tousoulis. SGLT2 inhibitors in the prevention of diabetic cardiomyopathy: Targeting the silent threat. World Journal of Cardiology 2024; 16(11): 669-672 doi: 10.4330/wjc.v16.i11.669 Abstract(78) \| Core Tip(68) \| Full Article(HTML)(319) \| Full Article with Cover (PDF)-611K(12) \| Audio-665K(0) \| Peer-Review Report-179K(9) \| Answering Reviewers-100K(11) \| Full Article (PDF)-354K(22) \| Full Article (XML)-44K(11) \| Times Cited (0) \| Total Visits (723) \| Open